Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Dec;7(6):846-51.
doi: 10.3748/wjg.v7.i6.846.

Copper transportion of WD protein in hepatocytes from Wilson disease patients in vitro

Affiliations

Copper transportion of WD protein in hepatocytes from Wilson disease patients in vitro

G Q Hou et al. World J Gastroenterol. 2001 Dec.

Abstract

Aim: To study the effect of copper transporting P-type ATPase in copper metabolism of hepatocyte and pathogenesis of Wilson disease (WD).

Methods: WD copper transporting properties in some organelles of the cultured hepatocytes were studied from WD patients and normal controls.These cultured hepatocytes were incubated in the media of copper 15 mg x L(-1) only, copper 15 mg x L(-1) with vincristine (agonist of P-type ATPase) 0.5mg x L(-1), or copper 15 mg x L(-1) with vanadate (antagonist of P-type ATPase) 18.39 mg x L(-1) separately. Microsome (endoplasmic reticulum and Golgi apparatus), lysosome, mitochondria, and cytosol were isolated by differential centrifugation. Copper contents in these organelles were measured with atomic absorption spectrophotometer, and the influence in copper transportion of these organelles by vanadate and vincristine were comparatively analyzed between WD patients and controls. WD copper transporting P-type ATPase was detected by SDS-PAGE in conjunction with Western blot in liver samples of WD patients and controls.

Results: The specific WD proteins (M(r)155,000 lanes) were expressed in human hepatocytes, including the control and WD patients. After incubation with medium containing copper for 2 h or 24 h, the microsome copper concentration in WD patients was obviously lower than that of controls, and the addition of vanadate or vincristine would change the copper transporting of microsomes obviously. When incubated with vincristine, levels of copper in microsome were significantly increased, while incubated with vanadate, the copper concentrations in microsome were obviously decreased. The results indicated that there were WD proteins, the copper transportion P-type ATPase in the microsome of hepatocytes. WD patients possessed abnormal copper transporting function of WD protein in the microsome, and the agonist might correct the defect of copper transportion by promoting the activity of copper transportion P-type ATPase.

Conclusion: Copper transportion P-type ATPase plays an important role in hepatocytic copper metabolism. Dysfunction of hepatocytic WD protein copper transportion might be one of the most important factors for WD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Western blotting analysis of WD protein separated from cultured human hepatocytes. M: Protein molecular mass markers; WD3: The hepatocytes of one WD patient; VE: Blood vessel endotheliocyte; S: Normal human hepatocytes.
Figure 2
Figure 2
Cu2+ levels in hepatic cytosol at different culturing conditions.
Figure 3
Figure 3
Cu2+ levels in hepatic microsome under different culturing conditions
Figure 4
Figure 4
Cu2+ levels in hepatic lysosome under different culturing conditions.
Figure 5
Figure 5
Cu2+ levels in hepatic mitochondria under different culturing conditions.

Similar articles

Cited by

References

    1. Terada K, Schilsky ML, Miura N, Sugiyama T. ATP7B (WND) protein. Int J Biochem Cell Biol. 1998;30:1063–1067. - PubMed
    1. Liang XLN (Eds) Neurological Genetics. Beijing: People’s Military Medicine Press; 2001. pp. 109–139.
    1. Ferenci P. Wilson's disease. Ital J Gastroenterol Hepatol. 1999;31:416–425. - PubMed
    1. Liang X, Hou G, Chen R, Xu P, Huang F, Wang Y, Yan Z. [A study of gene products encoded by Wilson disease gene] Zhonghua Gan Zang Bing Za Zhi. 2001;9:86–88. - PubMed
    1. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol. 1998;28 Suppl 1:28–36. - PubMed

Publication types